Skip to content
1st Counsel – Lifestyle
Author:
Centivax/Biocom
Centivax Closes $37 Million Financing to Accelerate Phase 2 Clinical Development of Universal Flu and Advance Follow-On Portfolio to Clinical Readiness
March 30, 2026